Office of Research COVID-19 Extramural Research Funding - Office of Research

COVID-19 Extramural Research Funding

Return to COVID-19 Research Working Group website

COVID-19 research funding opportunities relevant to UC Davis researchers will be added to this table as they are released by federal and state funding agencies, foundations, non-profits and industry partners. Please use the sorting and search tools below to find the opportunities most useful to you. Suggest additional entries by emailing msparling@ucdavis.edu.

The Office of Foundation and Corporate Engagement provides support for your proposals to foundations and corporate sponsors (fce@ucdavis.edu). All proposals for sponsored projects funded by government or non-profit sponsors are reviewed and authorized for submission by the Sponsored Programs Office (SPO). SPO is currently offering an expedited review process for all COVID-19 related proposals. Contact them at proposals@ucdavis.edu.

SponsorSponsor TypeProgram TitleLinkSponsor DeadlinePosted OnFunding Area(s)DescriptionAmount
Sorenson Impact FoundationFoundationEquitable and Resilient Recovery Grant Programhttps://sorensonimpactfoundation.org/grant-rfp/08/30/202008/04/2020Policy, Economics & LaborFor more information about this opportunity, please contact Molly McCarthy (molmccarthy@ucdavis.edu), Director of Foundation EngagementUp to $250,000
Economic Development Administration (EDA)Non-NIH FederalPublic Works and Economic Adjustment Assistance Programs including CARES Act Fundinghttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32169508/04/2020Community & Social Services; Policy, Economics & LaborCARES Act Recovery Assistance Projects: Successful applications will enable affected communities to respond to the impacts of the coronavirus pandemic by supporting affected businesses and communities, including by providing technical assistance to retain existing and hire new employees; by providing a range of skills-training and workforce development projects to help employees compete for high-quality jobs; and by developing and implementing strategies to diversify regional economies to create jobs in new or existing industries.Range from $150,000 to $1,000,000
Emergent VenturesAcademic Research InstituteSECOND ROUND: Emergent Ventures Fast Funding for COVID-19 Sciencehttps://fastgrants.org/07/21/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Humanities; Life Sciences; Policy, Economics, and LaborIf you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, the Emergent Ventures project at the Mercatus Center invites you to apply for a Fast Grant. A Fast Grant must be used solely to expedite COVID-19-related science, but the area of research is open. Fast grants are $10k to $500k and decisions are made in under 14 days.Up to $500,000
National Oceanic and Atmospheric Administration (NOAA)Non-NIH FederalAtmospheric Chemistry, Carbon Cycle, and Climate (AC4) Program - Climate Program Office 2021https://www.grants.gov/web/grants/search-grants.html?keywords=NOAA-OAR-CPO-2021-200638911/30/202007/21/2020Community & Social Services; Data Science, AI & Computing; Epidemiology & Public Health; Life SciencesThis year, AC4 has two competitions, and the foci are: Impacts of COVID-19 pandemic; and Urban atmospheric composition as related to the AEROMMA field campaign.Proposals should not exceed $200,000 per year
National Institute of CorrectionsNon-NIH FederalCOVID 19 – Operational Challenges for Correctionshttps://www.grants.gov/web/grants/view-opportunity.html?oppId=32808308/27/202007/21/2020Community & Social Services; Policy, Economics & LaborThe National Institute of Corrections (NIC) is seeking applications to support knowledge sharing around the nationwide correctional challenges that prisons, jails, and community services face during the COVID19 pandemic.$175,000 over 12 months
CiscoIndustry SponsorPandemic/COVID19 Science, Technology and Social Impacthttps://research.cisco.com/research#rfp-20200407/16/2020Data Science, AI & Computing; Engineering; Epidemiology & Public HealthFor more information about this opportunity, please contact Scott Stevenson (swstevenson@ucdavis.edu), Associate Director of Corporate EngagementNo limitations
National Institutes of Health (NIH - NIAID)NIHLimited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10)https://grants.nih.gov/grants/guide/pa-files/PAR-20-256.html07/13/2020 begins rolling deadline07/15/2020Community & Social Services; Epidemiology & Public Health; Life SciencesThe purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by “The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020” and “The Coronavirus Aid, Relief and Economic Security (CARES) Act”.It is expected that applicants will employ the most economical approaches, including securing academic discounts, to formulate a cost-effective budget while meeting users' needs.
National Science Foundation (NSF)Non-NIH FederalEcology and Evolution of Infectious Diseases (EEID)https://www.nsf.gov/pubs/2020/nsf20585/nsf20585.htm?WT.mc_id=USNSF_25&WT.mc_ev=click11/18/202007/13/2020Community & Social Services; Data Science, AI & Computing; Epidemiology & Public Health; Life SciencesThe multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be the quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among any host species, including but not limited to humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; the feedback between ecological transmission and evolutionary dynamics; and the cultural, social, behavioral, and economic dimensions of pathogen transmission. Research may be on zoonotic, environmentally-borne, vector-borne, or enteric pathogens of either terrestrial or aquatic systems and organisms, including diseases of animals and plants, at any scale from specific pathogens to inclusive environmental systems. Proposals for research on disease systems of public health concern to developing countries are strongly encouraged, as are disease systems of concern in agricultural systems. Investigators are encouraged to develop the appropriate multidisciplinary team, including for example, anthropologists, modelers, ecologists, bioinformaticians, genomics researchers, social scientists, economists, oceanographers, mathematical scientists, epidemiologists, evolutionary biologists, entomologists, parasitologists, microbiologists, bacteriologists, virologists, pathologists or veterinarians, with the goal of integrating knowledge across disciplines to enhance our ability to predict and control infectious diseases.
National Institutes of Health (NIH - NIAID)NIHNotice of Special Interest (NOSI) Regarding the Availability of Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-059.html07/01/202107/13/2020Epidemiology & Public Health; Life SciencesNIAID is issuing this Notice of Special Interest (NOSI) to highlight very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) research response. This NOSI replaces NOT-AI-20-034 which was rescinded with this issuance of this Notice.
National Institutes of Health (NIH - NIDDK)NIHMechanistic Studies of the Interaction Between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01)https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-021.html12/16/202007/13/2020Epidemiology & Public Health; Life SciencesThe purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases.Up to $750,000 direct costs over 3 years
National Institutes of Health (NIH - NCI)NIHNotice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows During Coronavirus Disease 2019 (COVID-19)https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-082.html08/14/202007/10/2020Epidemiology & Public Health; Life SciencesThrough this Notice of Special Interest (NOSI), the National Cancer Institute (NCI) announces an opportunity for current NCI funded Principal Investigators whose postdoctoral fellows have temporarily lost stipend support from a non-profit funder because of the COVID-19 global pandemic may apply for an administrative supplement to cover the postdoctoral fellow’s salary plus applicable F&A for the time and effort devoted to the NCI funded grant.
Open Road AllianceFoundationCharitable Grantshttps://openroadalliance.org/covid-19/06/26/2020Community & Social Services; Data Science, AI & Computing; Engineering; Epidemiology & Public Health; Humanities; Life Sciences; Policy, Economics & LaborFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populationshttps://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-119.html09/08/202006/17/2020Epidemiology / Public Health; Life SciencesThe purpose of this SEBI NOSI is to identify, analyze, and address the social, ethical, and behavioral factors likely to influence access and uptake of COVID-19 testing in underserved and/or vulnerable populations. Single or mixed methods approaches involving community partners will inform the development and evaluation of such testing programs. These studies will assess the ethical, historical, healthcare, social and contextual factors surrounding COVID-19 testing, as well as how cultural beliefs and attitudes, perceived expectations, and preferences influence the ability and willingness to get tested and participate in follow-up evaluations. Findings will be used to develop interventions to mitigate barriers to access and increase uptake of testing. Studies focused on unintended consequences of COVID-19 testing in these groups are also of interest when related to social and ethical issues.
National Institutes of Health (NIH)NIHNotice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populationshttps://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-120.html09/08/202006/17/2020Epidemiology / Public Health; Life SciencesThis Testing Research Projects NOSI will support supplements to individual NIH research awards that include community collaborations or partnerships to support COVID-19 testing (or have the capacity to ramp up quickly) to reach underserved and/or COVID-19 vulnerable populations.
National Institutes of Health (NIH)NIHGlobal Infectious Disease Research Training Program (D43 Clinical Trial Optional)https://grants.nih.gov/grants/guide/pa-files/PAR-20-229.html08/14/202006/17/2020Epidemiology / Public Health; Life SciencesThis Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research not including HIV/AIDS. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs.New awards: $1,150,000; Renewal Awards: $1,380,000 (Direct Costs)
National Institutes of Health (NIH)NIHNIH Director's Emergency Early Independence Awards (DP5) - Limited Submission!https://researchfunding.ucdavis.edu/#announcement/675309/04/2020*05/26/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life SciencesThis is a limited submission opportunity. UC Davis may only submit 2 applications as a campus. Please contact limsubmissions@ucdavis.edu for more information.Up to $1,000,000 direct costs over 5 years
National Institutes of Health (NIH)NIHNIH Director's Emergency Transformative Research Awards (R01)https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-20-020.html09/30/202005/26/2020Behavior and Psychology; Community and Social Services; Epidemiology / Public Health; Life SciencesThis FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act. All other Transformative Research Award applications must be submitted in response to RFA-RM-20-013. The NIH Director’s Transformative Research Award Program supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies.
Mercatus CenterAcademic Research InstituteCOVID-19 Response: A Call for Ideashttps://www.mercatus.org/features/covid-19-response-call-ideas04/27/2020 begins rolling deadline05/18/2020Behavior & Psychology; Community & Social Services; Data Science, AI & Computing; Epidemiology & Public Health; Humanities; Life Sciences; Policy, Economics & LaborThe Mercatus Center, building on its COVID-19 policy brief series, welcomes proposals for policy briefs, working papers, and articles that address the next round of challenges facing the United States and other countries in the response to the pandemic. See the solicitation for the specific questions of interest in the topics of restarting and reopening, institutional challenges, health and science policy, economic and regulatory policy, and monetary policy.
Draper Richards Kaplan FoundationFoundationCOVID-19 Urgent Response Initiativehttps://drive.google.com/file/d/1Dcj2zuFKE72caEBYz5ADOLDWeci802cD/view05/18/2020Behavior & Psychology; Community & Social Services; Data Science, AI & Computing; Engineering; Humanities; Policy, Economics & Labor; InstructionDRK is ready to find, fund, and support the people and ideas that are tackling the most acute and time-critical social problems caused by the Covid-19 pandemic right now. We want to help jumpstart projects that can realistically deploy within 30 days. We are best positioned to help work on the social problems caused by the pandemic versus direct mitigation via medical and scientific efforts. We will filter potential investments through the lens of urgency: Can this make large impact at scale? Can it be deployed quickly? And can DRK be catalytic in making that happen?Anticipated Range $50K-$100K
CETF and Rockefeller Philanthropy AdvisorsFoundationCOVID-19 Early Treatment Fund (CETF)http://www.treatearly.org/apply-for-funding05/12/2020Epidemiology & Public Health; Life SciencesFor more information about this opportunity, please contact Charlie Lemcke (cwlemcke@ucdavis.edu), Assistant Director of Corporate EngagementUp to $1M
Economic Development Administration (EDA)Non-NIH FederalEDA CARES Act Recovery Assistancehttps://www.eda.gov/coronavirus/05/12/2020Community & Social Services; Policy, Economics & LaborThe Coronavirus Aid, Relief, and Economic Security (CARES) Act provides the EDA with $1.5 billion for economic development assistance programs to help communities prevent, prepare for, and respond to coronavirus. EDA CARES Act Recovery Assistance provides a wide-range of financial assistance to communities and regions as they respond to and recover from the impacts of the pandemic. This includes: 1) Planning and Technical Assistance, 2) Construction of Infrastructure and Other Economic Development Projects, 3) Innovation Grants, and 4) Capitalization and Recapitalization of Revolving Loan Funds. Check that the proposed project fits the scope with the EDA regional office; applications reviewed on rolling basis.Typically up to $1,000,000
National Institutes of Health (NIBIB)NIHRapid Acceleration of Diagnostics (RADx)https://www.poctrn.org/radx04/28/2020 begins rolling deadline04/29/2020Epidemiology / Public Health; Life SciencesThe National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). RADx will support novel solutions that build the U.S. capacity for SARS-CoV-2 testing up to 100-fold above what is achievable with standard approaches.Varies by Phase
Federal Communications Commission (FCC)Non-NIH FederalCOVID-19 Telehealth Program and the Connected Care Pilot Programhttps://www.federalregister.gov/documents/2020/04/09/2020-07587/promoting-telehealth-for-low-income-consumers-covid-19-telehealth-program09/20/202004/24/2020Community and Social Services; Epidemiology / Public Health; Policy, Economics, and LaborThe Federal Communications Commission (Commission) establishes two programs: The COVID-19 Telehealth Program designed to distribute a $200 million appropriation from Congress under the Coronavirus Aid, Relief, and Economic Security (CARES) Act, to help health care providers provide connected care services to patients at their homes or mobile locations in response to the novel Coronavirus 2019 disease (COVID-19) pandemic, and the Connected Care Pilot Program (Pilot Program) designed to make available up to $100 million over three years to examine how the Universal Service Fund can help support the trend towards connected care services to consumers, particularly for low-income Americans and veterans.
National Institutes of Health (NIH)NIHAll open COVID-19 calls and Notices of Special Interest (NOSIs) from the Instituteshttps://grants.nih.gov/policy/natural-disasters/corona-virus.htm04/24/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and Labor; Education and TrainingThis page on the NIH website contains a table of all open COVID-19 calls and Notices of Special Interest (NOSIs) from the Institutes, in addition to other useful information. At this time there are too many NIH NOSIs to add to this table.Various
Henry Wheeler Center for Emerging and Neglected Diseases (CEND)University of CaliforniaCOVID Catalyst Fundinghttp://cend.globalhealth.berkeley.edu/covid-catalyst-rapid-funding-accelerate-covid-19-research/04/20/2020Epidemiology / Public Health; Life SciencesThe Covid Catalyst fund will provide catalytic seed funding for high-risk projects, as well as catalytic bridge funding for lower risk projects that likely will be successful in attracting government funding long-term. We will be able to fund projects for 3-6 months at a time or until a major milestone is reached. High-risk ideas that turn out to be not feasible should be allowed to fail rapidly so that another approach can be taken. Once the milestone is reached, repeat funding is possible to continue towards implementation.Up to $100,000
National Institutes of Health (NIH)NIHEmergency Competitive Revision to Existing NIH Awardshttps://grants.nih.gov/grants/guide/pa-files/PA-20-135.html04/10/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life Sciences; Policy, Economics, and LaborThe National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications for Emergency Competitive Revisions will be routed directly to the NIH awarding component listed on the NoA of the most recent parent award. Only applications submitted in response to an Emergency Notice of Special Interest (NOSI) published by an IC will be allowed to apply to this FOA.
GoogleIndustry SponsorGoogle Cloud research creditshttps://edu.google.com/programs/credits/research/?modal_active=none04/09/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Amy Skehan (arskehan@ucdavis.edu), Assistant Vice Chancellor of Foundation and Corporate Engagement
DoD-Air ForceNon-NIH FederalCommercial Solution Opening (CSO) COVID-19 Responsehttps://beta.sam.gov/opp/f48d23af514f494f819f0c33e9f40e17/view?keywords=FA3002-20-S-0002&sort=-relevance&index&is_active=true&page=109/30/202004/08/2020Behavior and Psychology; Community and Social Services; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborThe Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) has established a Commercial Solution Opening (CSO) seeking innovative, commercial technologies that propose new solutions and/or potentially new capabilities that fulfill requirements, close capability gaps, or provide potential technological advancements in support of the DAF ACT mission to provide relief, resilience, recovery, and stability to the nation in response to the COVID-19 pandemic. Of the seven mission focus areas, the initial Area of Interest is expected to be "Combating the Spread" (i.e. predictive analytics, next hotspot, threat to current activities, decision support, etc.). The CSO, a vehicle for future solicitations, is open to defense contractors, large and small businesses, and research institutions, with a focus on non-traditional organizations that do not typically work with the government. Rolling review of submissions through 9/30/2020
BARDANon-NIH FederalCoronaWatch/TechWatch Medical Countermeasureshttps://www.medicalcountermeasures.gov/request-barda-techwatch-meeting/04/07/2020Engineering; Life SciencesTo enable a rapid-response to the COVID-19 outbreak, BARDA has repurposed its existing TechWatch program to focus on COVID-19 medical countermeasures. These CoronaWatch submissions and meetings aim to give innovators and innovative companies a government-wide platform to discuss their ideas with U.S. government experts, and seek partnership opportunities with a wide range of potential federal partners. BARDA is particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
California Institute for Regenerative Medicine (CIRM)State of CaliforniaCIRM Rapid Research Fundshttps://www.cirm.ca.gov/about-cirm/newsroom/press-releases/03272020/stem-cell-agency-board-approves-5-million-emergency04/07/2020Epidemiology / Public Health; Life SciencesCIRM is issuing this special announcement to support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.Varies by Project Stage
DoD-Joint Acquisition Task Force (JATF)Non-NIH FederalCOVID-19 Request for Information (RFI)https://www.afwerx.af.mil/coronavirus.html04/07/2020Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Policy, Economics, and LaborDoD JATF is seeking input to shape its COVID-19 funding decisions focused on the accelerated ramp-up of production capacity for critical healthcare products such as masks, ventilators, test kits, and vaccines. JATF Focus Areas: 1) Combating Spread, 2) Welfare of Citizens, 3) Readiness, 4) Logistics, 5) Industrial base impacts, 6) Medical, 7) Other
PfizerIndustry SponsorCompetitive Grants Programhttps://www.pfizer.com/purpose/independent-grants/competitive-grants04/07/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
Allen Institute for AIPublic-Private PartnershipCOVID-19 Open Research Dataset Challengehttps://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge04/02/2020Data Science, AI, ComputingFor more information about this opportunity, please contact Robyn Ireland (rmbireland@ucdavis.edu), Assistant Director of Corporate Engagement$1,000 per task
BARDANon-NIH FederalBARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement: Molecular Diagnostics and Nonclinical Assayshttps://beta.sam.gov/opp/b4f7923443a448218d369209723141c5/view?keywords=BAA-20-100-SOL-0002%20&sort=-relevance&index&is_active=true&page=102/03/202104/02/2020Engineering; Life SciencesBiomedical Advanced Research and Development Authority (BARDA) is looking for: Molecular diagnostic assay for SARS-CoV-2 virus on existing FDA-cleared platform, Point-of-care diagnostic assay for detection of SARS-CoV-2 virus, Diagnostic assay for detection of COVID-19 disease, Nonclinical model development and screening for SARS-CoV-2 virus, Alternate vaccine delivery/administration and adjuvants, and Advanced manufacturing technologies. Rolling deadline.
BARDANon-NIH FederalBroad Agency Announcementhttps://beta.sam.gov/opp/1b46a4169fcb4902b9c4fcbb5bf981f7/view10/31/202004/02/2020Engineering; Life SciencesBiomedical Advanced Research and Development Authority (BARDA) is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003). COVID-19 response related Areas of Interest includes: Diagnostic assay for human coronavirus using existing FDA-cleared platforms; Point-of-care diagnostic assay for detection of SARS-CoV-2 virus, Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection), COVID-19 Vaccine, COVID-19 Therapeutics, Immunomodulators or therapeutics targeting lung repair, Pre-exposure and post-exposure prophylaxis, Respiratory protective devices, Ventilators, and Advanced Manufacturing Technologies.
DoE OSTP IBMPublic-Private PartnershipCOVID-19 High Performance Computing Consortiumhttps://covid19-hpc-consortium.org/04/02/2020Behavior and Psychology; Data Science, AI, Computing; Engineering; Epidemiology / Public Health; Life SciencesThe COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus.  Researchers seeking to access the Consortium’s resources should submit a simple project proposal that will be reviewed for potential impact, computational feasibility, overall resource requirements and timeline.
Gates Foundation, Wellcome Trust, Mastercard, & CZIFoundationCOVID-19 Therapeutics Acceleratorhttps://www.therapeuticsaccelerator.org/04/02/2020Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Traci Galbaugh (tlgalbaugh@ucdavis.edu), Senior Director of Foundation Engagement
Ginkgo BioworksIndustry SponsorFree Access to Ginkgo Platformhttps://www.ginkgobioworks.com/2020/03/17/ginkgo-commits-25m-of-free-access-to-our-platform-for-partner-covid-19-projects/04/02/2020Data Science, AI, Computing; Epidemiology / Public Health; Life SciencesFor more information about this opportunity, please contact Jamie Shattuck (jkshattuck@ucdavis.edu), Senior Director of Corporate Engagement
NIH-NIAIDNIHCollaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)https://grants.nih.gov/grants/guide/pa-files/PAR-18-781.html09/09/202004/02/2020Life SciencesNIAID has funded the use and further development of the CC mouse lines for immunology and infectious disease research, including SARS-CoV.
NIH-NIAID & NIANIHInvestigator Initiated Extended Clinical Trial (R01)https://grants.nih.gov/grants/guide/pa-files/PAR-20-139.html09/13/2020 next deadline03/30/2020Epidemiology / Public Health; Life SciencesThis Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs. Consultation with IC staff is strongly encouraged prior to the submission of the clinical trial implementation application. This FOA is not intended for support of clinical trials that do not require an extended project period of 6 or 7 years.